跳至主要内容
临床试验/IRCT20180803040681N1
IRCT20180803040681N1已完成2 期

A randomized controlled trial on the efficacy and safety of Metformin in severe traumatic brain injury

Tabriz University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • a definite diagnosis of head trauma
  • GCS score of 8 or less
  • patients on mechanical ventilator
  • written informed consent signed by patient’s legal guardian

排除标准

  • time of admission to ICU of more than 48 hours
  • Per Os (NPO) status on admission day
  • previous treatment with metformin or any other biguanide medication
  • blood glucose level of =150mg/dL or =70mg/dL
  • simultaneous participation in another clinical trial
  • serum creatinine level of 1.5mg/dL or more
  • serum lactate level of 2.5mmol/L or more
  • arterial pH of less than 7.25
  • serum bicarbonate of 13mEq/L or less
  • moderate to severe renal impairment (estimated glomerular filtration rate (eGFR) of below 45mL/min/1.73m2)
  • acute liver failure

研究者

相似试验